Biocorrx Inc. (OTCMKTS:BICX – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.35 and traded as low as $0.2980. Biocorrx shares last traded at $0.2980, with a volume of 761 shares traded.
Biocorrx Stock Up 8.3%
The stock has a market capitalization of $8.84 million, a PE ratio of -1.86 and a beta of 0.19. The business’s 50-day moving average is $0.33 and its two-hundred day moving average is $0.35.
Biocorrx (OTCMKTS:BICX – Get Free Report) last issued its quarterly earnings data on Friday, May 15th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.03. The firm had revenue of $0.21 million for the quarter, compared to analysts’ expectations of $0.22 million.
Biocorrx Company Profile
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Featured Stories
- Five stocks we like better than Biocorrx
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
